↓ Skip to main content

Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

Overview of attention for article published in Psychopharmacology, April 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
1 X user
patent
29 patents

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
49 Mendeley
Title
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone
Published in
Psychopharmacology, April 2010
DOI 10.1007/s00213-010-1838-3
Pubmed ID
Authors

David Andrew Tompkins, Ryan K. Lanier, Joseph A. Harrison, Eric C. Strain, George E. Bigelow

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
United Kingdom 1 2%
Australia 1 2%
Unknown 45 92%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 12%
Student > Ph. D. Student 5 10%
Student > Bachelor 5 10%
Researcher 5 10%
Student > Master 5 10%
Other 10 20%
Unknown 13 27%
Readers by discipline Count As %
Medicine and Dentistry 20 41%
Psychology 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Nursing and Health Professions 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 8%
Unknown 13 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#6,446,325
of 22,896,955 outputs
Outputs from Psychopharmacology
#1,843
of 5,353 outputs
Outputs of similar age
#30,275
of 95,206 outputs
Outputs of similar age from Psychopharmacology
#14
of 37 outputs
Altmetric has tracked 22,896,955 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 5,353 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,206 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.